ReviewOncoTargets and therapy2015

Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor-positive advanced breast cancer.

J Thaddeus BeckPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.